Syntese AS

Syntese AS is a word-leading manufacturer Mesalazine (Ph.Eur) / Mesalamine (USP); CAS 89-57-6, an API used in treating Inflammatory Bowel Diseases i.e. Ulcerative Colitis, Crohn Disease.Syntese Mesalazine is manufactured in multi-tons per year in the companys highly automated production facility in Denmark. Syntese is FDA approved and holds CEP from EDQM.Having more nearly 30 years of experience in product- and process development Syntese guarantees its customers high quality product together with extensive R&D support and comprehensive regulatory compliance.